- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04917237
Non-disabling Ischemic Cerebrovascular Event With Apathy
Non-disabling Ischemic Cerebrovascular Event With Apathy: A Prospective Registry Trail
Study Overview
Status
Conditions
Detailed Description
Transient ischemic attack (TIA) and acute minor ischemic stroke, are common and may leave impermanent or mild neurological deficit, they are termed as non-disabling ischemic cerebrovascular disease (NICE). TIA and minor stroke exhibit the common substantial risk factors for early stroke recurrence and epidemiological characteristic, with approximately 10 to 20% of patients having a stroke within 3 months after the index event.
Previous studies has shown that post-stroke apathy (PSA) affects one in three stroke patients, which is consistently associated with a worse level of functional recovery, poorer overall health and poorer quality of life. However, still little is known about the development of TIA and minor stroke patients with apathy. Thus, it is imperative to find the relationships between baseline PSA and probable incident stroke in these patients.
NICE is an attractive researching area globally. According to the large quantities of NICE patients in China and the low standardized therapeutic rate, the awareness of TIA and minor stroke is largely insufficient. The purpose of the present NICE-A study is to establish the prevalence, predictors and evolution of symptoms of PSA in TIA and minor stroke patients during the first post-stroke year.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Xiaoying Bi, MD, PhD
- Phone Number: 86-13795274796
- Email: bixiaoying2013@163.com
Study Contact Backup
- Name: Bingying Du, MD, PhD
- Phone Number: 86-15800614142
- Email: 15800614142@163.com
Study Locations
-
-
Shanghai
-
Shanghai, Shanghai, China, 200433
- Recruiting
- Changhai hospital
-
Contact:
- Bingying Du, PhD
- Phone Number: 15800614142
- Email: 15800614142@163.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
≥18 years old Onset of a minor stroke (National Institute of Health stroke scale, NIHSS≤3) and TIA elapsed time from last episode to registry <1 month
Exclusion Criteria:
patients who refused to participate in the research, and patients who failed to complete the follow-up protocol.
patients with malignant tumors, or patients with severe liver or kidney disease, whose life expectancy is less than 1 year.
patients who received endovascular or thrombolytic therapy.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Death
Time Frame: 12 months
|
Death from any cause
|
12 months
|
Death
Time Frame: 3 months
|
Death from any cause
|
3 months
|
Death
Time Frame: 6 months
|
Death from any cause
|
6 months
|
Stroke recurrence
Time Frame: 3 months
|
Ischemic stroke
|
3 months
|
Stroke recurrence
Time Frame: 6 months
|
Ischemic stroke
|
6 months
|
Stroke recurrence
Time Frame: 12 months
|
Ischemic stroke
|
12 months
|
Death
Time Frame: 1 month
|
Death from any cause
|
1 month
|
Stroke recurrence
Time Frame: 1 month
|
Ischemic stroke
|
1 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Hemorrhagic stroke
Time Frame: 3 months
|
Cerebral hemorrhage and subaraclmoid hemorrhage
|
3 months
|
Hemorrhagic stroke
Time Frame: 6 months
|
Cerebral hemorrhage and subaraclmoid hemorrhage
|
6 months
|
Hemorrhagic stroke
Time Frame: 12 months
|
Cerebral hemorrhage and subaraclmoid hemorrhage
|
12 months
|
Functional outcome
Time Frame: 3 months
|
Modified Rankin Scale ≥3
|
3 months
|
Functional outcome
Time Frame: 6 months
|
Modified Rankin Scale ≥3
|
6 months
|
Functional outcome
Time Frame: 12 months
|
Modified Rankin Scale ≥3
|
12 months
|
Hemorrhagic stroke
Time Frame: 1 month
|
Cerebral hemorrhage and subaraclmoid hemorrhage
|
1 month
|
Functional outcome
Time Frame: 1 month
|
Modified Rankin Scale ≥3
|
1 month
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Xiaoying Bi, MD, PhD, Department of Changhai Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NICE-A
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.RecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, CryptogenicSingapore, Philippines
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Vanderbilt University Medical CenterPatient-Centered Outcomes Research Institute; University of Alabama at BirminghamEnrolling by invitationStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Engagement, Patient | Stroke HemorrhagicUnited States
-
University of MinnesotaAmerican Occupational Therapy FoundationRecruitingStroke | Stroke Sequelae | Stroke Hemorrhagic | Stroke IschemicUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Michael Smith Foundation for...RecruitingStroke | Stroke, Ischemic | Stroke Hemorrhagic | Chronic StrokeCanada
-
University of CincinnatiMedical University of South Carolina; University of California, Los Angeles; University...RecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke HemorrhagicUnited States
-
Turkish Stroke Research and Clinical Trials NetworkElectroCore INC; Turkish Neurological SocietyCompletedStroke | Stroke, Ischemic | Stroke, Acute | Stroke, HemorrhagicTurkey